Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,085 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.
Wasko UN, Jiang J, Dalton TC, Curiel-Garcia A, Edwards AC, Wang Y, Lee B, Orlen M, Tian S, Stalnecker CA, Drizyte-Miller K, Menard M, Dilly J, Sastra SA, Palermo CF, Hasselluhn MC, Decker-Farrell AR, Chang S, Jiang L, Wei X, Yang YC, Helland C, Courtney H, Gindin Y, Muonio K, Zhao R, Kemp SB, Clendenin C, Sor R, Vostrejs WP, Hibshman PS, Amparo AM, Hennessey C, Rees MG, Ronan MM, Roth JA, Brodbeck J, Tomassoni L, Bakir B, Socci ND, Herring LE, Barker NK, Wang J, Cleary JM, Wolpin BM, Chabot JA, Kluger MD, Manji GA, Tsai KY, Sekulic M, Lagana SM, Califano A, Quintana E, Wang Z, Smith JAM, Holderfield M, Wildes D, Lowe SW, Badgley MA, Aguirre AJ, Vonderheide RH, Stanger BZ, Baslan T, Der CJ, Singh M, Olive KP. Wasko UN, et al. Among authors: tsai ky. Nature. 2024 Nov 12. doi: 10.1038/s41586-024-08084-7. Online ahead of print. Nature. 2024. PMID: 39533066 No abstract available.
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.
Quandt Z, Jacob S, Fadlullah MZH, Wu C, Wu C, Huppert L, Levine LS, Sison P, Tsai KK, Chow M, Kang JH, Hwang J, Lee JC, Oglesby A, Venegas J, Brintz BJ, Tan AC, Anderson MS, Rosenblum MD, Young A, Daud AI. Quandt Z, et al. Among authors: tsai kk. BJC Rep. 2024 Jun 24;2(1):46. doi: 10.1038/s44276-024-00057-7. BJC Rep. 2024. PMID: 39516257
Reply to Editorial Comment on "To Hold or Continue Blood Thinners? A Retrospective Analysis on Outcomes of Holmium Laser Enucleation of the Prostate (HoLEP) in Patients who Either Held or Continued Antiplatelet/Anticoagulation Therapy".
Xu P, Dean NS, Tsai K, Ganesh M, Khondakar N, Guo JN, Krambeck AE. Xu P, et al. Among authors: tsai k. Urology. 2024 Nov 5:S0090-4295(24)00980-4. doi: 10.1016/j.urology.2024.10.078. Online ahead of print. Urology. 2024. PMID: 39510212 No abstract available.
Effects of urinary organophosphate flame retardants in susceptibility to attention-deficit/hyperactivity disorder in school-age children.
Wang LJ, Chao HR, Chen CC, Chen CM, You HL, Tsai CC, Tsai CS, Chou WJ, Li CJ, Tsai KF, Cheng FJ, Kung CT, Li SH, Wang CC, Ou YC, Lee WC, Huang WT. Wang LJ, et al. Among authors: tsai kf. Ecotoxicol Environ Saf. 2024 Nov 6;287:117281. doi: 10.1016/j.ecoenv.2024.117281. Online ahead of print. Ecotoxicol Environ Saf. 2024. PMID: 39509783
2,085 results